ERAMILERMIN
UNII NV5WP4JRH3

Substance Identification & Data

This profile provides standardized clinical and technical data for Eramilermin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NV5WP4JRH3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3082932-43-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
NV5WP4JRH3
CAS Registry Number
3082932-43-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ERAMILERMIN
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
14118
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
Eramilermin
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Eramilermin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Eramilermin

Common Names & Synonyms

recombinant human myeloid-derived growth factor (MYDGF, Uniprot: Q969H8) variant (A1>ins), produced in Escherichia coli BL21 (DE3.D/E) cells, containing deletions of the λDE3 phage genes D and E, not glycosylated

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record